tert-Butyl 3-(3-aminopropyl)azetidine-1-carboxylate

Catalog No.: 
ACECHN603
CAS No.: 
1205750-48-6
Molecular Formula: 
C11H22N2O2
Molecular Weight: 
214.31
tert-Butyl 3-(3-aminopropyl)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$74.00In stockInquiry
50mg97%$125.00In stockInquiry
100mg97%$212.00In stockInquiry
250mg97%$382.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(3-aminopropyl)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(3-aminopropyl)azetidine-1-carboxylate
MDL No.MFCD14582364
Molecular FormulaC11H22N2O2
Molecular Weight214.31
SMILESO=C(N1CC(CCCN)C1)OC(C)(C)C
InChI KeyPCVWQHKPZXIGDH-UHFFFAOYSA-N
Synonymtert-butyl 3-(3-aminopropyl)azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-(3-aminopropyl)-, 1,1-dimethylethyl ester;1-Boc-3-(3-aminopropyl)azetidine
CAS No.1205750-48-6

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACECHN603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACECHN603 route product structure diagram
    ACECHN6031205750-48-6In Stock
Inquiry

2. ACECHN603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACECHN603 route product structure diagram
    ACECHN6031205750-48-6In Stock
Inquiry

3. ACECHN603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACECHN603 route product structure diagram
    ACECHN6031205750-48-6In Stock
Inquiry

Comments (0)